Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933

Form Type: S-1/A

Filing Date: 2022-05-24

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2022-05-19

View Filing

S-1 - General form for registration of securities under the Securities Act of 1933

Form Type: S-1

Filing Date: 2022-05-12

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2022-05-12

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2022-05-02

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2022-04-07

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2022-04-01

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2022-03-28

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2022-03-17

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2022-02-28

View Filing